• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Animal & Veterinary

  • Print
  • Share
  • E-mail


FDA Veterinarian Newsletter September/October 1998 Volume XIII, No V

On August 19, CVM held a public meeting to solicit views on how the Center can best meet its statutory obligations.

Under Section 406(b) of the FDA Modernization Act (FDAMA) of 1997, the Agency is required to consult with its external stakeholders. Following these consultations, FDA is to develop and publish a plan for achieving compliance with each of its obligations under the Federal Food, Drug, and Cosmetic Act.

A total of 85 people attended the CVM meeting, which was held in Washington, DC. Fifteen (15) CVM stakeholders made formal presentations, and there were informal presentations by several others. Stakeholders making formal presentations included representatives from animal drug industry associations (such as the Animal Health Institute), veterinary medicine associations (such as the American Veterinary Medical Association), producer groups (such as the National Pork Producers Council), feed trade associations (such as the National Grain and Feed Association), animal science societies, State feed control officials, and consumer groups.

The stakeholders commented on various issues including implementation of the Animal Drug Availability Act (ADAA), antimicrobial resistance, the drug review process, CVM resources and priorities, user fees, third party review, enforcement, international activities, cooperation/collaboration between the Center and its stakeholders, science infrastructure, and field issues.

A transcript of this meeting may be requested in writing from the Freedom of Information Office (HFI-35), Food and Drug Administration, 5600 Fishers Lane, Room 12A-16, Rockville, MD 20857. The transcript also is included on the FDA Home Page (http://www.fda.gov/).